Biliverdin administration protects against endotoxin-induced acute lung injury in rats

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 289, Issue 6 33-6, 2005, Pages

  Sarady Andrews, Judit K ^b   Liu, Fang ^b   Gallo, David ^a   Nakao, Atsunori ^b   Overhaus, Marcus ^b   Öllinger, Robert ^c   Choi, Augustine M ^b   Otterbein, Leo E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Biliverdin reductase; Heme oxygenase 1; Inflammation; Oxidative stress

Indexed keywords

BILIRUBIN; BILIVERDIN; ENDOTOXIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; HEME; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 6; MESSENGER RNA;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CECUM; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTOXEMIA; GEL MOBILITY SHIFT ASSAY; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLITIS; LUNG ENDOTHELIUM; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTIC SHOCK; SURVIVAL RATE;

ANIMALS; BILIVERDINE; CAPILLARY PERMEABILITY; ENDOTHELIAL CELLS; HEME OXYGENASE-1; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; LUNG; MACROPHAGES; MALE; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; SHOCK, SEPTIC; TIME;

EID: 27944467221     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00458.2004     Document Type: Article

References (32)

1. Ahmad Z, Salim M, and Maines MD. Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress. J Biol Chem 277: 9226-9232, 2002.
2. Baranano DE, Rao M, Ferris CD, and Snyder SH. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci USA 99: 16093-16098, 2002.
3. Barañano DE, Wolosker H, Bae BI, Barrow RK, Snyder SH, and Ferris CD. A mammalian iron ATPase induced by iron. J Biol Chem 275: 15166-15173, 2000.
4. Brouard S, Otterbein LE, Anrather J, Tobiasch E, Bach FH, Choi AMK, and Soares MP. Carbon monoxide generated by heme oxygenase-1 suppresses endothelial cell apoptosis. J Exp Med 192: 1015-1026, 2000.
5. Chapman JT, Otterbein LE, Elias JA, and Choi AM. Carbon monoxide attenuates aeroallergen-induced inflammation in mice. Am J Physiol Lung Cell Mol Physiol 281: L209-L216, 2001.
6. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, and Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278: H643-H651, 2000.
7. Farrear JA, Jauma A, Ribo JM, Peire MA, Parellada PP, Roque-Choua S, Bienvenue E, and Seta P. The antioxidant role of bile pigments evaluated by chemical tests. Bioorg Med Chem 2: 181-185, 1994.
8. Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Barañano DE, Doré S, Poss KD, and Snyder SH. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1: 152-157, 1999.
9. Fink MP and Heard SO. Laboratory models of sepsis and septic shock. J Surg Res 49: 186-196, 1990.
10. Fondevila C, Shen XD, Tsuchiyashi S, Yamashita K, Csizmadia E, Lassman C, Busuttil RW, Kupiec-Weglinski JW, and Bach FH. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 40: 1333-1341, 2004.
11. Gopinathan V, Miller NJ, Milner AD, and Rice-Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett 349: 197-200, 1994.
12. Gunther L, Berberat PO, Haga M, Brouard S, Smith RN, Soares MP, Bach FH, and Tobiasch E. Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet cell function/survival after transplantation. Diabetes 51: 994-999, 2001.
13. Kutty RK and Maines MD. Hepatic heme metabolism: possible role of biliverdin in the regulation of heme oxygenase activity. Biochem Biophys Res Commun 122: 40-46, 1984.
14. Martins GA, Da Gloria Da Costa Carvalho M, and Rocha Gattass C. Sepsis: a follow-up of cytokine production in different phases of septic patients. Int J Mol Med 11: 585-591, 2003.
15. Nakao A, Otterbein LE, Overhaus M, Sarady JK, Tsung A, Kimizuka K, Nalesnik NA, Kaizu T, Uchiyama T, Liu F, Murase N, Bauer AJ, and Bach FH. Biliverdin protects the functional integrity of a transplanted syngeneic small bowel. Gastroenterology 127: 595-606, 2004.
16. 16a. Ollinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, Csizmadia E, Graca-Souza AV, Liloia A, Soares MP, Otterbein LE, Usheva A, Yamashita K, and Bach FH. Bilibrubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation. 112: 1030-1039, 2005.
17. Otterbein LE, Bach FH, Alam J, Soares M, Lu HT, Wysk M, Davis RJ, Flavell RA, and Choi AMK. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 6: 422-428, 2000.
18. Otterbein LE, Mantell LL, and Choi AMK. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 276: L688-L694, 1999.
19. Otterbein LE, Sylvester SL, and Choi AMK. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol 13: 595-601, 1995.
20. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, and Soares MP. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 9: 183-190, 2003.
21. Pallua N, Low JF, and von Heimburg D. Pathogenic role of interleukin-6 in the development of sepsis. II. Significance of anti-interleukin-6 and anti-soluble interleukin-6 receptor-α antibodies in a standardized murine contact burn model. Crit Care Med 31: 1595-1601, 2003.
22. Sarady JK, Otterbein SL, Liu F, Otterbein LE, and Choi AM. Carbon monoxide modulates endotoxin-induced production of granulocyte macrophage colony-stimulating factor in macrophages. Am J Respir Cell Mol Biol 27: 739-745, 2002.
23. Sarady JK, Zuckerbraun BS, Bilban M, Wagner O, Usheva A, Liu F, Ifedigbo E, Zamora R, Choi AM, and Otterbein LE. Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. FASEB J 18: 854-856, 2004.
24. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercelotti G, Choi AMK, Bach FH, and Soares MP. Carbon monoxide generated by heme-oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166: 4185-4194, 2001.
25. Sedlak TW and Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 113: 1776-1182, 2004.
26. 25a. Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal 6: 831-849, 2004.
27. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 239: 1043-1046, 1987.
28. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, Novotny L, and Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160: 449-456, 2002.
29. Wang HD, Yamaya M, Okinga S, Jia YX, Kamanaka M, Takahashi B, Guo LY, Ohriu T, and Sasaki H. Bilirubin ameliorates bleomycin-induced pulmonary fibrosis in rats. Am J Respir Crit Care Med 165: 406-411, 2002.
30. Wichterman KA, Baue AE, and Chaudry IH. Sepsis and septic shock-a review of laboratory models and a proposal. J Surg Res 29: 189-201, 1980.
31. Yamashita K, McDaid J, Ollinger R, Tsui TY, Berberat PO, Usheva A, Csizmadia E, Smith RN, Soares MP, and Bach FH. Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allografts. FASEB J 18: 765-767, 2004.
32. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AM, and Lee PJ. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 278: 1248-1258, 2003.